We are currently developing the world’s first comprehensive platform for digital precision medicine.
How can you prove sobriety? Check your smart phone.
Previct Drugs detects drug use right there in your smartphone, using eye-scanning created through our patented AI. Our latest weapon in the struggle against dependency is the perfect complement to our existing platform for digital dependency care and relapse prevention. Previct Drugs also makes it possible to intervene in a growing problem: polysubstance dependence (dependency on multiple substances). With Previct Drugs, the user scans their eye with their smartphone, and the result is instantly delivered to the caregiver. An invaluable aid in ongoing drug dependency treatment. With time, our current algorithms will evolve to make it possible to predict relapse for drug- and polysubstance dependence in the same way that our AI predictions already work for alcohol dependency.
Previct Drugs – a part of a well-established care platform.
Previct Drugs builds on an already well-established digital health platform that we developed in early 2014 and have been continuously honing ever since. This means Previct Drugs can hit the ground running. Besides our existing platform and our digital knowledge bank focusing on drug dependency care and relapse prevention, we also offer well-developed sales channels and a fantastic support organization.
Polysubstance dependence – a bigger challenge than ever.
Just think how simple it would be if addictions such as alcohol, gambling, and drugs stood at a well-defined distance from mental illness. Unfortunately, in reality it doesn’t work that way. There is no one explanatory- or treatment model for all these conditions today. This is exactly where Previct Drugs can make a difference. Previct creates a holistic picture of the user’s condition, which gives the caretaker much better conditions for success. With Previct, large portions of the care is conducted by patients themselves, in their own home environment while the care provider receives that information in real time. That makes for efficient and cost-effective care.
A piece of the puzzle in the fight against polysubstance dependence.
Previct Drugs has created the world’s first digital, individually customized care platform for polysubstance dependence. Besides being able to treat alcohol, gambling and drug dependencies, Previct is also a giant step towards being an individualized tool for behavioral change. All in your smartphone! The strength of the Previct platform is that it creates a palette of care options for different types of dependencies, based on data measured from each individual user of the platform. Beyond that, it gives support for customized behavioral change while also being a communication tool with increased support for the patient, twenty-four hours a day.
Who can become polysubstance addicted?
The simple truth is that anybody can become addicted to several substances. When we talk about polysubstance dependence, we might picture a person sitting alone on a park bench, prepared to ingest a little bit of just about anything they can find. In fact, the most common type of person with what we call polysubstance dependence is somebody who finds themself caught in dependence due to completely legal prescriptions received in connection with challenges such as accidents or mental illness. This means polysubstance dependence can be expressed in many ways, such as mixing alcohol and drugs, but also with a combination of different types of drugs. Polysubstance dependence can impact anybody right in the middle of normal, everyday life. Put simply, polysubstance dependence is already right where you are, in normal, everyday life.
Best in the world at digital biomarkers.
When we launched Previct Alcohol, Kontigo Care became the first in the world to digitally track sobriety biomarkers. Now we are aiming to be able to detect the influence of drugs. Our patented AI for alcohol and drug use prevention stands alone in today’s market.
The Previct platform has already won many prestigious awards. Beginning in 2018 we were honored with the eHealth Award for the Nordic countries’ best e-health solution! Now that is something to be really proud of!
We are not afraid to completely commit, we know that the care industry is with us on this. When we asked our partners how important it is to them to be able to detect polysubstance dependence, on a scale of 1 to 10, the majority answered 8 or even higher. That’s why it’s extra exciting to soon be able to give the health care industry och everybody who is struggling with dependence new possibilities.”
Maria Sjölund, Sales Manager
Det går att investera i Kontigo Care.
Right now we are on the threshold of a decisive breakthrough for all of dependence care. A possibility to detect drug use through eye scanning with smartphones which will also provide the possibility to tackle polysubstance dependence. This will open up new possibilities within our current markets and give us extra momentum in new markets. Kontigo Care is an Uppsala based company that was introduced on NASDAQ First North in 2015. Since the start, our goal has been to revolutionize dependence care with cutting edge digital solutions. We realized early on that a modern, humane drug treatment is digital.